Large-scale testing (Phase 3)Looking for participantsNCT07555392
What this trial is testing
A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Who this might be right for
Active Immunisation for Chikungunya Virus Infection
Bharat Biotech International Limited 1,000